These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3497138)

  • 21. Mapping of an HLA-DRw52-associated determinant on DR beta 1 molecules.
    Ballas M; Eiermann TH; Wölpl A; Goldmann SF
    Tissue Antigens; 1990 Nov; 36(5):187-93. PubMed ID: 1710076
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biochemical and functional evidence that an MT3 supertypic determinant defined by a monoclonal antibody is carried on the DR molecule on HLA-DR7 cell lines.
    Horibe K; Flomenberg N; Pollack MS; Adams TE; Dupont B; Knowles RW
    J Immunol; 1984 Dec; 133(6):3195-202. PubMed ID: 6208273
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of a novel HLA-DQ specificity: serological and immunochemical analyses by a monoclonal antibody.
    Ishikawa N; Kojima H; Nakayama T; Kunikane H; Hawkin S; Fukasawa Y; Ikeda H; Ogasawara K; Kasahara M; Tajima Y
    Immunogenetics; 1987; 26(3):143-9. PubMed ID: 3497872
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serological biochemical and functional characterisation of three different HLA-DR monoclonal antibodies derived from C57BL6 mice.
    Sachs JA; Fernandez N; Kurpisz M; Okoye R; Ogilvie J; Awad J; Labeta M; Festenstein H
    Tissue Antigens; 1986 Oct; 28(4):199-207. PubMed ID: 2949394
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An influenza A virus-specific and HLA-DRw8-restricted T cell clone cross-reacting with a transcomplementation product of the HLA-DR2 and DR4 haplotypes.
    Gomard E; Hénin Y; Sterkers G; Masset M; Fauchet R; Lévy JP
    J Immunol; 1986 Jun; 136(11):3961-7. PubMed ID: 2422266
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The molecules recognized by anti-MT2 alloantisera and anti-MT2-like (DRw52) monoclonal antibodies are different.
    Schiffenbauer J; Bono C; Schwartz BD
    Hum Immunol; 1985 Apr; 12(4):223-33. PubMed ID: 3872866
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Two dimensional gel analysis of HLA-DR2 associated HLA-D clusters.
    Nakatsuji T; Moriya K; Tsuji K
    Tokai J Exp Clin Med; 1986 May; 11(2):125-31. PubMed ID: 3031855
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monoclonal antibodies to sheep MHC class II molecules recognize all HLA-D or subsets of HLA-D region products.
    Puri NK; de Kretser T; Brandon MR
    Hum Immunol; 1987 Nov; 20(3):195-207. PubMed ID: 3501780
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monoclonal antibody to a supertypic determinant associated with HLA-DRw52.
    Eiermann TH; Krause S; Wölpl A; Ballas M; Goldmann SF
    Hybridoma; 1989 Aug; 8(4):467-74. PubMed ID: 2476377
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A monoclonal antibody recognizes a novel HLA-DQ specificity, DQWa].
    Ishikawa N
    Hokkaido Igaku Zasshi; 1985 Sep; 60(5):635-42. PubMed ID: 2416664
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Structural analysis of DR and DQ molecules among three HLA-D clusters associated with HLA-DR4].
    Ikeda H
    Hokkaido Igaku Zasshi; 1985 Nov; 60(6):898-907. PubMed ID: 2417927
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A monoclonal antibody detecting an HLA-DQwl-related determinant.
    Koning F; Raghoebar J; Schreuder GM; Schuurman R; Bruning H
    Tissue Antigens; 1985 Aug; 26(2):100-9. PubMed ID: 2414859
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Detection of hybrid DQ molecules by the use of T cell clone and 2D-gel analyses].
    Hawkin S
    Hokkaido Igaku Zasshi; 1986 Nov; 61(6):892-901. PubMed ID: 3493964
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Two-dimensional gel analysis of a second family of class II molecules by polymorphic HLA-DR4,5, and w9 monoclonal antibodies.
    Maeda H; Hirata R; Okuyama M; Thompson A; Tohyama H
    J Immunol; 1984 May; 132(5):2478-84. PubMed ID: 6201545
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence for chemical differences in HLA-DR molecules on autologous acute lymphoblastic leukemia and B-lymphoblastoid cell lines.
    Graf L; Pesando JM
    Blood; 1987 Jan; 69(1):7-11. PubMed ID: 3491643
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monoclonal antibodies to HLA-DP, DQ, and DR determinants: functional effects on the activation and proliferation of normal and EBV-transformed B cells.
    Howard DR; Eaves AC; Takei F
    Exp Hematol; 1986 Oct; 14(9):887-95. PubMed ID: 2428652
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of seven new monoclonal antibodies against human DR, DR + DP and DQ1 + DQ3 antigens.
    Horejsí V; Nĕmec M; Angelisová P; Kristofová H; Gorga JC; Hilgert I
    Tissue Antigens; 1986 Nov; 28(5):288-97. PubMed ID: 2435017
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A human-human hybridoma antibody (TrB12) defining subgroups of HLA-DQw1 and -DQw3.
    Kolstad A; Hansen T; Hannestad K
    Hum Immunol; 1987 Nov; 20(3):219-31. PubMed ID: 2830209
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An overview of the restriction fragment length polymorphism of the HLA-D region: its application to individual D-, DR- typing by computerized analyses.
    Tilanus MG; Hongming F; van Eggermond MC; vd Bijl M; D'Amaro J; Schreuder GM; de Vries RR; Giphart MJ
    Tissue Antigens; 1986 Oct; 28(4):218-27. PubMed ID: 2880410
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alloreactive T-cell clones raised in an HLA-B/D crossing-over family dissect HLA-DR5 and HLA-DQw3 subtypes.
    Eiermann TH; Winkelmann S; Ballas M; Wölpl A; Goldmann SF
    Hum Immunol; 1990 Oct; 29(2):117-30. PubMed ID: 1701168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.